Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ZEB1 Modifies VE-Cadherin Signaling in Lymphatic Endothelial Cells.

Microcirculation (New York, N.Y. : 1994)·2026
Same author

Investigating the association of fetal sex and hypertensive pregnancy outcomes across varying conception types: a retrospective cohort study.

Journal of gynecology obstetrics and human reproduction·2026
Same author

Distinct DNA methylation signatures in maternal blood reveal unique immune cell shifts in preeclampsia and the pregnancy-postpartum transition.

PloS one·2026
Same author

A pan-cancer compendium of 1,294 plasma cell-free DNA methylomes and fragmentomes enabling multicancer detection.

Nature cancer·2026
Same author

Influence of fluid shear stress on human limbal epithelial cells.

Biochemistry and biophysics reports·2026
Same author

Meta-analysis examining fetal sex-specific placental DNA methylation intensities and estimated cell composition post IVF.

Molecular human reproduction·2025
Same journal

A Method for Fabricating Long Decellularized Scaffolds from Skeletal Muscle.

Tissue engineering. Part C, Methods·2026
Same journal

Design and Fabrication of Demountable 3D Microphysiological Systems.

Tissue engineering. Part C, Methods·2026
Same journal

Generation and Characterization of Induced Pluripotent Stem Cell Line UAEUi001-A from an Emirati Patient with Ventricular Septal Defect.

Tissue engineering. Part C, Methods·2026
Same journal

Automated Abnormal Vessel Detection in Re-Endothelialized Mouse Lungs: A Proof of Concept.

Tissue engineering. Part C, Methods·2026
Same journal

Tissue-Engineered Brain-Mimetic Niches to Model Braintropic Triple-Negative Breast Cancer Metastasis.

Tissue engineering. Part C, Methods·2026
Same journal

A Defined 3D Hydrogel Model Recapitulates Key Transcriptomic Features of Lung Adenocarcinoma.

Tissue engineering. Part C, Methods·2026
See all related articles

Related Experiment Video

Updated: Mar 22, 2026

A Human Corneal Organ Culture Model of Descemet's Stripping Only with Accelerated Healing Stimulated by Engineered Fibroblast Growth Factor 1
12:36

A Human Corneal Organ Culture Model of Descemet's Stripping Only with Accelerated Healing Stimulated by Engineered Fibroblast Growth Factor 1

Published on: July 22, 2022

5.1K

Dextran Preserves Native Corneal Structure During Decellularization.

Amy P Lynch1,2, Samantha L Wilson3,4, Mark Ahearne1,2

  • 11 Trinity Centre for Bioengineering, Trinity Biomedical Sciences Institute , Trinity College Dublin, Dublin, Republic of Ireland .

Tissue Engineering. Part C, Methods
|April 13, 2016
PubMed
Summary
This summary is machine-generated.

Dextran effectively reduces corneal swelling during decellularization, preserving native tissue structure and biomechanical properties for corneal regeneration scaffolds. This method enhances cell viability on decellularized tissues.

More Related Videos

Corneal Donor Tissue Preparation for Descemet's Membrane Endothelial Keratoplasty
10:46

Corneal Donor Tissue Preparation for Descemet's Membrane Endothelial Keratoplasty

Published on: September 17, 2014

15.8K
Decellularization of the Murine Cardiopulmonary Complex
08:34

Decellularization of the Murine Cardiopulmonary Complex

Published on: May 30, 2021

3.5K

Related Experiment Videos

Last Updated: Mar 22, 2026

A Human Corneal Organ Culture Model of Descemet's Stripping Only with Accelerated Healing Stimulated by Engineered Fibroblast Growth Factor 1
12:36

A Human Corneal Organ Culture Model of Descemet's Stripping Only with Accelerated Healing Stimulated by Engineered Fibroblast Growth Factor 1

Published on: July 22, 2022

5.1K
Corneal Donor Tissue Preparation for Descemet's Membrane Endothelial Keratoplasty
10:46

Corneal Donor Tissue Preparation for Descemet's Membrane Endothelial Keratoplasty

Published on: September 17, 2014

15.8K
Decellularization of the Murine Cardiopulmonary Complex
08:34

Decellularization of the Murine Cardiopulmonary Complex

Published on: May 30, 2021

3.5K

Area of Science:

  • Biomaterials Science
  • Tissue Engineering
  • Ophthalmology

Background:

  • Corneal regeneration relies on decellularized scaffolds.
  • Tissue swelling during decellularization limits scaffold application.
  • Maintaining native corneal structure is crucial for function.

Purpose of the Study:

  • Investigate dextran's role in reducing swelling during corneal decellularization.
  • Assess dextran's impact on preserving corneal ultrastructure and biomechanical properties.
  • Evaluate the viability of cells on dextran-treated decellularized corneal scaffolds.

Main Methods:

  • Corneal decellularization using Triton X-100, sodium dodecyl sulfate, and nucleases.
  • Supplementation of decellularization solutions with 5% dextran.
  • Quantitative DNA analysis, transmission electron microscopy (TEM), anisotropy analysis, and compressive modulus testing.

Main Results:

  • Dextran significantly reduced corneal swelling, maintaining dimensions similar to native tissue.
  • DNA content was reduced by 96% regardless of dextran presence.
  • TEM analysis showed native corneal architecture preservation when dextran was present throughout the protocol.
  • Dextran maintained native-like biomechanical properties and anisotropy.

Conclusions:

  • Dextran is effective in preventing significant corneal swelling during decellularization.
  • Dextran enhances the preservation of native corneal ultrastructure and biomechanical integrity.
  • Dextran-treated decellularized corneal scaffolds support cell viability, making them promising for corneal regeneration.